BioCryst Pharmaceuticals Stock Price

0.46 (3.08%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.46 3.08% 15.38 16:14:42
Open Price Low Price High Price Close Price Prev Close
15.00 14.83 15.45 15.38 14.92
Bid Price Ask Price Spread News
15.17 15.45 0.28 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
18,706 2,746,282 $ 15.20 $ 41,737,538 - 3.36 - 18.48
Last Trade Time Type Quantity Stock Price Currency
16:29:57 5 $ 15.38 USD


Draw Mode:

BioCryst Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.75B 178.87M 159.09M $ 17.81M $ - -1.08 -12.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -99.45k 2.60%

more financials information »

BioCryst Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.1515.6814.8015.172,031,5460.231.52%
1 Month15.6516.2814.56515.382,135,940-0.27-1.73%
3 Months16.2718.4814.00115.912,647,358-0.89-5.47%
6 Months10.1518.489.2314.363,295,4595.2351.53%
1 Year3.7018.483.3610.145,073,68011.68315.68%
3 Years7.6218.481.386.474,137,0917.76101.84%
5 Years4.6918.481.386.362,958,59010.69227.93%

BioCryst Pharmaceuticals Description

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Your Recent History
BioCryst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.